BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18684944)

  • 1. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
    Obeid M
    J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
    Panaretakis T; Joza N; Modjtahedi N; Tesniere A; Vitale I; Durchschlag M; Fimia GM; Kepp O; Piacentini M; Froehlich KU; van Endert P; Zitvogel L; Madeo F; Kroemer G
    Cell Death Differ; 2008 Sep; 15(9):1499-509. PubMed ID: 18464797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin exposure dictates the immunogenicity of cancer cell death.
    Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G
    Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role and mechanism of chaperones calreticulin and ERP57 in restoring trafficking to mutant HERG‑A561V protein.
    Wu Y; Huang X; Zheng Z; Yang X; Ba Y; Lian J
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34212985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.
    Liu SH; Lee WJ; Lai DW; Wu SM; Liu CY; Tien HR; Chiu CS; Peng YC; Jan YJ; Chao TH; Pan HC; Sheu ML
    Mol Oncol; 2015 Apr; 9(4):834-49. PubMed ID: 25619450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
    Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
    Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
    Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
    Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.
    Yang Y; Li XJ; Chen Z; Zhu XX; Wang J; Zhang LB; Qiang L; Ma YJ; Li ZY; Guo QL; You QD
    PLoS One; 2012; 7(12):e50811. PubMed ID: 23251389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum stress-mediated membrane expression of CRT/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells.
    Xu Q; Chen C; Lin A; Xie Y
    Oncotarget; 2017 Aug; 8(35):58754-58764. PubMed ID: 28938593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.
    Zitvogel L; Kepp O; Senovilla L; Menger L; Chaput N; Kroemer G
    Clin Cancer Res; 2010 Jun; 16(12):3100-4. PubMed ID: 20421432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecto-calreticulin in immunogenic chemotherapy.
    Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
    Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death.
    Panaretakis T; Kepp O; Brockmeier U; Tesniere A; Bjorklund AC; Chapman DC; Durchschlag M; Joza N; Pierron G; van Endert P; Yuan J; Zitvogel L; Madeo F; Williams DB; Kroemer G
    EMBO J; 2009 Mar; 28(5):578-90. PubMed ID: 19165151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
    Martins I; Kepp O; Schlemmer F; Adjemian S; Tailler M; Shen S; Michaud M; Menger L; Gdoura A; Tajeddine N; Tesniere A; Zitvogel L; Kroemer G
    Oncogene; 2011 Mar; 30(10):1147-58. PubMed ID: 21151176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.
    Kuang XL; Liu F; Chen H; Li Y; Liu Y; Xiao J; Shan G; Li M; Snider BJ; Qu J; Barger SW; Wu S
    J Neurosci Res; 2014 Oct; 92(10):1319-29. PubMed ID: 24860980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of ERp57 with calreticulin: Analysis of complex formation and effects of vancomycin.
    Frasconi M; Chichiarelli S; Gaucci E; Mazzei F; Grillo C; Chinazzi A; Altieri F
    Biophys Chem; 2012 Jan; 160(1):46-53. PubMed ID: 21996511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calreticulin controls the rate of assembly of CD1d molecules in the endoplasmic reticulum.
    Zhu Y; Zhang W; Veerapen N; Besra G; Cresswell P
    J Biol Chem; 2010 Dec; 285(49):38283-92. PubMed ID: 20861015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death.
    Kepp O; Gdoura A; Martins I; Panaretakis T; Schlemmer F; Tesniere A; Fimia GM; Ciccosanti F; Burgevin A; Piacentini M; Eggleton P; Young PJ; Zitvogel L; van Endert P; Kroemer G
    Cell Cycle; 2010 Aug; 9(15):3072-7. PubMed ID: 20699648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin exposure increases cancer immunogenicity.
    Clarke C; Smyth MJ
    Nat Biotechnol; 2007 Feb; 25(2):192-3. PubMed ID: 17287754
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.
    Sukkurwala AQ; Martins I; Wang Y; Schlemmer F; Ruckenstuhl C; Durchschlag M; Michaud M; Senovilla L; Sistigu A; Ma Y; Vacchelli E; Sulpice E; Gidrol X; Zitvogel L; Madeo F; Galluzzi L; Kepp O; Kroemer G
    Cell Death Differ; 2014 Jan; 21(1):59-68. PubMed ID: 23787997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-stage inhibition of autophagy enhances calreticulin surface exposure.
    Li DD; Xie B; Wu XJ; Li JJ; Ding Y; Wen XZ; Zhang X; Zhu SG; Liu W; Zhang XS; Peng RQ
    Oncotarget; 2016 Dec; 7(49):80842-80854. PubMed ID: 27825129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.